12:00 AM
Feb 20, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Eviplera regulatory update

The Scottish Medicines Consortium recommended the use of Eviplera emtricitabine/tenofovir/rilpivirine on the National Health Service (NHS) in Scotland to treat HIV-1 infection in antiretroviral treatment-naïve adults with a viral load <=100,000 HIV-1 RNA...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >